Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · Real-Time Price · USD

10.52

+0.41 (4.06%)

Aug 5, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	40.18	36.79	26.63	13.27	23.77	21.1
Cash & Short-Term Investments	40.18	36.79	26.63	13.27	23.77	21.1
Cash Growth	77.20%	38.12%	100.72%	-44.19%	12.67%	-30.46%
Accounts Receivable	18.76	23.22	12.88	8.81	1.55	-
Inventory	1.86	1.57	1.06	2.16	0.58	-
Other Current Assets	6.08	5.47	3.55	2.62	0.83	1.29
Total Current Assets	66.88	67.04	44.12	26.86	26.73	22.39
Other Long-Term Assets	4.94	3.51	0.82	0.01	0.21	0.03
Total Assets	71.82	70.55	44.95	26.86	26.94	22.41

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.28	4.64	3.24	3.78	2.39	0.78
Accrued Expenses	3.06	5.64	3.43	3.75	2.22	0.88
Current Portion of Leases	-	-	0	0.02	-	-
Unearned Revenue	0.25	0.25	0.25	-	-	-
Total Current Liabilities	9.59	10.52	6.92	7.55	4.61	1.65
Long-Term Debt	-	-	19.34	30.93	24.9	4.99
Other Long-Term Liabilities	24.56	24.56	24.56	0	-	-
Total Long-Term Liabilities	24.56	24.56	43.9	30.93	24.9	4.99
Total Liabilities	34.15	35.08	50.82	38.49	29.51	6.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	191.23	189.91	145.61	144.31	142.59	140.8
Additional Paid-in Capital	74.42	73.75	66.96	62.07	56.8	53.21
Accumulated Other Comprehensive Income	1.24	1.24	1.24	1.24	1.24	1.24
Retained Earnings	-229.22	-229.42	-219.68	-219.25	-203.2	-179.49
Shareholders' Equity	37.68	35.47	-5.87	-11.62	-2.57	15.77
Total Liabilities & Equity	71.82	70.55	44.95	26.86	26.94	22.41

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0	19.34	30.95	24.9	4.99
Net Cash (Debt)	40.18	36.79	7.29	-17.68	-1.13	16.11
Net Cash Growth	1108.76%	404.36%	-	-	-	-46.90%
Net Cash Per Share	1.85	1.29	0.27	-0.67	-0.04	0.62
Book Value	37.68	35.47	-5.87	-11.62	-2.57	15.77
Book Value Per Share	1.74	1.24	-0.22	-0.44	-0.10	0.61
Tangible Book Value	37.68	35.47	-5.87	-11.62	-2.57	15.77
Tangible Book Value Per Share	1.74	1.24	-0.22	-0.44	-0.10	0.61

SEC Filings: 10-K · 10-Q